东宝生物：不向下修正“东宝转债”转股价格

Core Viewpoint - Dongbao Biological announced that it will not adjust the conversion price of its convertible bonds despite triggering conditions for a downward adjustment due to stock prices being below 90% of the conversion price for 15 trading days [1] Group 1: Company Actions - The company’s stock price has been below the conversion price of 6.63 yuan per share for 15 trading days, triggering the conditions for a downward adjustment of the "Dongbao Convertible Bonds" [1] - The board of directors held a meeting on October 15, 2025, and decided not to adjust the conversion price of the "Dongbao Convertible Bonds" [1] - From October 16, 2025, to April 15, 2026, if the conditions for a downward adjustment are triggered again, the company will not propose a downward adjustment plan [1] Group 2: Future Considerations - After April 16, 2026, if the conditions for a downward adjustment are triggered again, the board will convene to decide whether to exercise the right to adjust the conversion price [1]